← Back to Search

Visual Cues and Education for Memory Loss in Long Term Care Communities

N/A
Waitlist Available
Led By Rebecca Davis, PhD
Research Sponsored by Grand Valley State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing whether adding special signs and elements, as well as educational sessions, to senior living communities will help residents find their way more effectively.

Eligible Conditions
  • Alzheimer's Dementia
  • Alzheimer's Disease
  • Memory Disorders
  • Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Wayfinding Speed at 12 months
Secondary outcome measures
Change in Life Space at 12 months
Change in Spatial Tracking (Time spent at each life space zone) at 12 months
Change in Spatial Tracking - Life space at 12 months
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Spaced retrieval educationExperimental Treatment2 Interventions
This condition will have signage and cues as in Arm 2 added to the care communities. In addition, a spaced retrieval (SR) memory intervention strategy will be implemented individually for each resident participating in the study to help them remember the presence and function of the environmental wayfinding cues.
Group II: Salient CuesExperimental Treatment1 Intervention
Special signs and salient cues will be added to the community along the routes being measured for wayfinding. The cues will be comprised of pictures, objects, and signage.
Group III: ControlActive Control1 Intervention
There will be no modifications to décor or signage in the existing care community, and no education on wayfinding. However, subjects will receive the same testing that is provided for the other arms at the designated time periods.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spaced Retrieval Education
2019
N/A
~180
Salient Cues
2019
N/A
~180

Find a Location

Who is running the clinical trial?

Michigan State UniversityOTHER
184 Previous Clinical Trials
601,235 Total Patients Enrolled
Grand Valley State UniversityLead Sponsor
12 Previous Clinical Trials
8,507 Total Patients Enrolled
Rebecca Davis, PhDPrincipal Investigator - Grand Valley State University
Grand Valley State University

Media Library

Salient Cues Clinical Trial Eligibility Overview. Trial Name: NCT03537729 — N/A
Alzheimer's Dementia Research Study Groups: Spaced retrieval education, Control, Salient Cues
Alzheimer's Dementia Clinical Trial 2023: Salient Cues Highlights & Side Effects. Trial Name: NCT03537729 — N/A
Salient Cues 2023 Treatment Timeline for Medical Study. Trial Name: NCT03537729 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for individuals to take part in this trial?

"Per the information available on clinicaltrials.gov, recruitment for this medical study has been concluded. It was first made visible to public audiences in April of 2019 and had its last recorded update on November 17th 2022. Although participation is no longer possible, there are 783 other trials actively recruiting patients at present time."

Answered by AI
~29 spots leftby Apr 2025